Ranolazine 42571-0324
Product NDC
42571-0324- Manufacturer
- Micro Labs Limited
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 1, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA211745
Need to source Ranolazine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ranolazine | 500 mg/1 |
Drug Class
Anti-anginal [EPC]Anti-anginal [EPC]Cytochrome P450 2D6 Inhibitors [MoA]
Packaging Options(4)
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-05)
100 BLISTER PACK in 1 CARTON (42571-324-11) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (42571-324-32)
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-60)
180 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-64)